Dr. Yuan Zhang is qualified as patent
attorney and attorney-at-law. She counsels both Chinese and international
clients in in various matters relating to IP rights in the pharma and life science
industry, including prosecution, due diligence, FTO analysis, patentability
analysis, licensing and post-grant proceedings. Her practice focuses on matters
including chemical entities, biosimilars, antibodies, diagnosis and
pharmaceutical formulations. Since 2020, she participated in the legislative
discussion on various topics, including patent linkage, data exclusivity, and
patent term extension.
Education
Dr. Zhang received her PhD in
chemistry from Iowa State University (United States) in 2011, with a focus in
biochemistry and protein science. She received her bachelor's degree in
chemistry from Nankai University in 2006
Legal Consulting
Providing IP due diligence
service for a Shanghai-based biotech company in their Nasdaq listing project
(2021);
Providing IP due diligence
service for an investment company for them to invest in a Guangzhou-based
biotech company (2021);
Providing IP due diligence
service for a Shanghai-based biotech company to license-in an ophthalmic drug
(2021);
Providing IP due diligence
service for a Shanghai-based biotech company to license-in a nasal
anti-inflammatory medical device (2021);
Providing IP due diligence
service for a Zhejiang-based biotech company in their HKEX listing project
(2020);
Providing IP due diligence
service for a Beijing-based biotech company in their HKEX listing project
(2020);
Dispute Resolution
Representing an Israel
pharmaceutical company to defend their medical use patent (2021)
Representing an Austrian pharmaceutical
company to defend their polymer patent (2021)
Publication
“Doctrine of equivalents for life science
patents in China” IAM Life Sciences 2020: Key issues for senior life
sciences executives, 53-57, Yuan Zhang, Zongliang (Stephen) Zou
“Preparing for China’s Patent Linkage System”
IAM Life Sciences 2021: Key issues for senior life sciences executives, 71-75,
Yuan Zhang, Zongliang (Stephen) Zou
“Discussion on the coordination between data
exclusivity and patent linkage” Zhichanli, April 2021, Yuan Zhang,
Zongliang (Stephen) Zou
“Discussion on the Necessity of Establishing
the Transitional Measures for the Early Settlement Mechanism of Drug Patent
Disputes” Zhichanli, July 2021, Yuan Zhang, Zongliang (Stephen) Zou